Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
BJU Int. 2010 Jan;105(1):16-20. doi: 10.1111/j.1464-410X.2009.08706.x. Epub 2009 Jul 6.
To investigate the association between body mass index (BMI) and histology of renal cell carcinoma (RCC) in a contemporary cohort, as obesity is increasingly prevalent in the USA and might be contributing to the increasing incidence of RCC, but little is known about the relationship of obesity with the different histological subtypes of RCC.
From January 2000 to December 2007 we identified 1640 patients with renal cortical tumours undergoing surgical extirpation at our institution, and who had their BMI recorded. Multivariable logistic regression models were used to test the association of BMI with RCC histology.
The median (interquartile range) BMI was 28 (25-32) kg/m(2) and 38% of patients were classified as obese (BMI >30 kg/m(2)). After adjusting for tumour size, age, gender, American Society of Anesthesiologists score, estimated glomerular filtration rate, hypertension, diabetes mellitus and smoking, the BMI was significantly associated with clear-cell histology; the odds ratios were 1.04 for each unit of BMI (95% confidence interval, CI, 1.02-1.06; P < 0.001) and 1.48 when comparing obese vs non-obese patients (95% CI 1.19-1.84; P < 0.001). In the subgroup of patients with RCC (excluding benign renal cortical tumours), BMI was still an independent predictor of clear-cell histology (odds ratio 1.04, 95% CI 1.02-1.06, P = 0.001).
These results suggest that BMI is an independent predictor of clear-cell histology in patients with a renal cortical tumour. While the aetiology of this phenomenon requires further study, these findings might have implications in determining a patient's risk of harbouring a clear-cell RCC and in subsequent treatment recommendations.
在当代队列中研究体重指数(BMI)与肾细胞癌(RCC)组织学之间的关系,因为肥胖在美国越来越普遍,可能导致 RCC 发病率上升,但肥胖与 RCC 的不同组织学亚型之间的关系知之甚少。
我们从 2000 年 1 月至 2007 年 12 月在我们的机构中确定了 1640 名接受肾皮质肿瘤手术切除的患者,记录了他们的 BMI。多变量逻辑回归模型用于测试 BMI 与 RCC 组织学之间的关联。
BMI 的中位数(四分位间距)为 28(25-32)kg/m²,38%的患者被归类为肥胖(BMI>30kg/m²)。在调整肿瘤大小、年龄、性别、美国麻醉师协会评分、估计肾小球滤过率、高血压、糖尿病和吸烟后,BMI 与透明细胞组织学显著相关;BMI 每增加一个单位的比值比为 1.04(95%置信区间,CI,1.02-1.06;P<0.001),与肥胖患者相比,非肥胖患者的比值比为 1.48(95%CI,1.19-1.84;P<0.001)。在排除良性肾皮质肿瘤的 RCC 患者亚组中,BMI 仍然是透明细胞组织学的独立预测因子(比值比 1.04,95%CI 1.02-1.06,P=0.001)。
这些结果表明,BMI 是肾皮质肿瘤患者透明细胞组织学的独立预测因子。虽然这种现象的病因需要进一步研究,但这些发现可能对确定患者是否存在透明细胞 RCC 的风险以及随后的治疗建议有影响。